These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7098141)

  • 1. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):181-96. PubMed ID: 7098141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
    Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract]   [Full Text] [Related]  

  • 6. Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.
    Aubry WM; Sparks JC; Braunstein GD
    Mt Sinai J Med; 1984 Apr; 51(2):132-7. PubMed ID: 6610110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis].
    Persichetti S; Sagliaschi G; Clemenzia G; Angelitti A; Gallo G; Maggi S; Ponzio R; Punzo G; Tozzo C
    Minerva Med; 1992 Nov; 83(11):721-4. PubMed ID: 1461543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
    Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dialysis bone disease in children. Six cases (author's transl)].
    Luciani JC; Ferran JL; Dumas ML; Meunier P; Dumas R
    Nouv Presse Med; 1977 Nov; 6(39):3616-9. PubMed ID: 607175
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal osteodystrophy].
    Servodio Iammarrone C; Di Cicco N; Di Salle F
    Chir Organi Mov; 1987; 72(2):125-36. PubMed ID: 3677868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormalities of calcium metabolism in patients on hemodialysis: changes of ionized-calcium-regulating hormones and acid-bse balance during hemodialysis (author's transl)].
    Nakamura I
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):413-27. PubMed ID: 7401394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Limited results in the treatment with salmon calcitonin in subjects with renal osteodystrophy].
    Carcheri G; Falletti P; Fraguglia C; Ervo R; Lupo S; Cravino GL
    Clin Ter; 1986 Feb; 116(3):195-9. PubMed ID: 3698527
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of photon absorptiometry in renal osteodystrophy (author's transl)].
    Samizadeh A; Loew H; Busch G; Müller H; Losse H
    Klin Wochenschr; 1977 Oct; 55(20):1005-1011. PubMed ID: 200791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of calcitonin therapy in renal osteodystrophy.
    Delano BG; Baker R; Gardner B; Wallach S
    Nephron; 1973; 11(5):287-93. PubMed ID: 4753519
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological evolution of renal osteodystrophy after decreasing dialysate calcium from 1.75 to 1.6 mmol/l.
    Jean G; Chazot C; Charra B
    Clin Nephrol; 2002 Jan; 57(1):91-2. PubMed ID: 11837809
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of calcitonin on hemodialysis patients with hypercalcemia and renal osteodystrophy.
    Carney SL; Epstein MT
    Uremia Invest; 1984-1985; 8(2):97-101. PubMed ID: 6537690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.